Literature DB >> 20089606

A novel ultra-porous titanium dioxide ceramic with excellent biocompatibility.

Roya Sabetrasekh1, Hanna Tiainen, S Petter Lyngstadaas, Janne Reseland, Håvard Haugen.   

Abstract

The current study compares biocompatibility, cell growth and morphology, pore diameter distribution, and interconnectivity of a novel titanium dioxide (TiO(2)) bone graft substitute granules with three different commercially available bone graft granules Natix, Straumann BoneCeramic, and Bio-Oss. Human primary mesenchymal stem cells were cultured on the bone graft substitutes and cell viability and proliferation were evaluated after 1 and 3 days. The microstructural properties of the bone graft substitutes were evaluated by scanning electron microscopy, micro-computed tomography analysis, and mechanical testing. The cell viability and proliferation, porosity, interconnectivity, open pore size, and surface area-to-volume ratio of TiO(2) granules were significantly higher than commercial bone granules (Bio-Oss and Straumann BoneCeramic).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20089606     DOI: 10.1177/0885328209354925

Source DB:  PubMed          Journal:  J Biomater Appl        ISSN: 0885-3282            Impact factor:   2.646


  10 in total

1.  Alginate hydrogel enriched with enamel matrix derivative to target osteogenic cell differentiation in TiO2 scaffolds.

Authors:  Helen Pullisaar; Anders Verket; Krisztina Szoke; Hanna Tiainen; Håvard J Haugen; Jan E Brinchmann; Janne E Reseland; Esben Østrup
Journal:  J Tissue Eng       Date:  2015-03-12       Impact factor: 7.813

2.  Porous Titanium Granules in comparison with Autogenous Bone Graft in Femoral Osseous Defects: A Histomorphometric Study of Bone Regeneration and Osseointegration in Rabbits.

Authors:  Eudoxie Pepelassi; Despina Perrea; Ismene Dontas; Christian Ulm; Ioannis Vrotsos; Stefan Tangl
Journal:  Biomed Res Int       Date:  2019-12-14       Impact factor: 3.411

3.  Dual-functional porous and cisplatin-loaded polymethylmethacrylate cement for reconstruction of load-bearing bone defect kills bone tumor cells.

Authors:  Zhule Wang; Liebert Parreiras Nogueira; Håvard Jostein Haugen; Ingrid Cm Van Der Geest; Patricia Caetano de Almeida Rodrigues; Dennis Janssen; Thom Bitter; Jeroen J J P van den Beucken; Sander Cg Leeuwenburgh
Journal:  Bioact Mater       Date:  2021-12-29

Review 4.  3D Bioprinted Scaffolds for Bone Tissue Engineering: State-Of-The-Art and Emerging Technologies.

Authors:  Zahra Yazdanpanah; James D Johnston; David M L Cooper; Xiongbiao Chen
Journal:  Front Bioeng Biotechnol       Date:  2022-04-11

5.  Computational characterization of the structural and mechanical properties of nanoporous titania.

Authors:  Ziwei Xu; Li Zhang; Lin Wang; Jie Zuo; Mingli Yang
Journal:  RSC Adv       Date:  2019-05-16       Impact factor: 4.036

6.  Porous Titanium Granules and Blood for Bone Regeneration around Dental Implants: Report of Four Cases and Review of the Literature.

Authors:  Andreas Thor
Journal:  Case Rep Dent       Date:  2013-03-07

7.  Evaluation of dental socket healing after using of porous titanium granules: Histologic and histomorphometric assessment in dogs.

Authors:  Mohammad Tavakoli; Ahmad Moghareabed; Tayebeh Farsam; Fatemeh Mashhadi Abbas; Hamid Badrian; Navid Khalighinejad
Journal:  Dent Res J (Isfahan)       Date:  2012-09

8.  Dimensional Ridge Preservation with a Novel Highly Porous TiO(2) Scaffold: An Experimental Study in Minipigs.

Authors:  Hanna Tiainen; Anders Verket; Håvard J Haugen; S Petter Lyngstadaas; Johan Caspar Wohlfahrt
Journal:  Int J Biomater       Date:  2012-10-03

9.  Biocompatibility of Portland Cement Modified with Titanium Oxide and Calcium Chloride in a Rat Model.

Authors:  Narjes Hoshyari; Hossein Labbaf; Nooshin Jalayer Naderi; Ali Kazemi; Farshid Bastami; Maryam Koopaei
Journal:  Iran Endod J       Date:  2016-03-20

10.  Bioactivation of titanium dioxide scaffolds by ALP-functionalization.

Authors:  A Sengottuvelan; P Balasubramanian; J Will; A R Boccaccini
Journal:  Bioact Mater       Date:  2017-03-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.